Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease-Reference-Cited by-同舟云学术

Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease

Published:2007-10-17 Issue:1 Volume:2009 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

van Hilten ¹,Ramaker Claudia C¹,Stowe Rebecca²,Ives Natalie²

Affiliation:

1. Leiden University of Medical Center; Department of Neurology; Albinusdreef 2 Leiden Netherlands 2333 ZA

2. University of Birmingham; University of Birmingham Clinical Trials Unit; Division of Medical Sciences, Robert Aitken Institute Edgbaston Birmingham UK B15 2TT

Publisher

Wiley

Subject

Pharmacology (medical)

Reference52 articles.

1. Does combined levodopa and bromocriptine therapy in Parkinson's disease prevent late motor complications?;Alarcón;European Journal of Neurology,1998

2. Long-term double masked trial of early treatment with L-dopa plus bromocriptine versus L-dopa alone in Parkinson's disease. Interim results;Bakheit;European Neurology,1990

3. Early combination of bromocriptine and levodopa in Parkinson's disease: A prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage;Giménez-Roldan;Clinical Neuropharmacology,1997

4. Long term bromocriptine treatment in de novo parkinsonian patients;Herskovits;Medicina (B Aires),1988

5. Bromocriptine and levodopa in early combination in Parkinson's Disease; first results of the Collaborative European Multicentric Trial;Olsson JE and The European Multicentric Trial Group,1990

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromocriptine therapy: Review of mechanism of action, safety and tolerability;Clinical and Experimental Pharmacology and Physiology;2022-06-22

2. The Interplay Between Depression and Parkinson´s Disease: Learning the Link Through Ca2+/cAMP Signaling;Current Protein & Peptide Science;2020-12-31

3. Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease;BMJ Open;2014-12

4. Bromocriptine for type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2013-01-31